BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 4882918)

  • 1. In vivo antibody production by spleen cells after incubation in vitro with heterologous antilymphocyte plasma.
    Jeejeebhoy HF; Rabbat AG
    Nature; 1968 Dec; 220(5174):1350-2. PubMed ID: 4882918
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunosuppressive effect of antilymphocyte sera produced by sensitization with different lymphoid tissues.
    Sterling WA; Elveback LR; Shorter RG
    Transplantation; 1970 Oct; 10(4):297-301. PubMed ID: 4927385
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of antilymphocyte serum on the thymus.
    Levey RH; Taub R
    Transplant Proc; 1969 Mar; 1(1):424-8. PubMed ID: 4944253
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological effects of antithymus serum and antilymphocyte serum.
    Nagaya H; Sieker HO
    Prog Immunobiol Stand; 1970; 4():225-9. PubMed ID: 4098263
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive potency of antiserum to thymus glands prepared with ribosomal fraction.
    Nagaya H; McKenzie WN; Kilburn KH; Sieker HO
    J Immunol; 1970 Feb; 104(2):511-3. PubMed ID: 4904884
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of heterologous antilymphocyte and antithymocyte sera in rabbit skin allotransplantation.
    Govallo VI; Kosmiadi GA
    Folia Biol (Praha); 1968; 14(4):293-5. PubMed ID: 4878579
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of strain-specific effects in the immunosuppressive action of heterologous antithymus sera in mice.
    Shorter RG; Elveback LR
    Transplantation; 1970 Mar; 9(3):253-8. PubMed ID: 4908612
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of immunosuppressive potency of rabbit antimouse antisera raised in response to various murine tissues.
    Sutthiwan P; Shorter RG; Hallenbeck GA
    J Surg Res; 1970 Apr; 10(4):151-7. PubMed ID: 4908685
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin.
    Tursi A; Greaves MF; Torrigiani G; Playfair JH; Roitt IM
    Immunology; 1969 Nov; 17(5):801-11. PubMed ID: 4900922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative in vitro and in vivo activity of antilymphocyte serum raised by immunization with thymic, splenic, and lymph node lymphocytes.
    Ono K; Bell P; Kashiwagi N; Starzl TE
    Surgery; 1969 Oct; 66(4):698-703. PubMed ID: 4898466
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of different lymphoid target cells in determining the correlation of in vitro and in vivo activities of antilymphocyte sera.
    Végh P; Balough E; Jánossy T; Erdös E
    Z Immunitatsforsch Exp Klin Immunol; 1974 Jun; 147(2):162-74. PubMed ID: 4283007
    [No Abstract]   [Full Text] [Related]  

  • 14. Mode of recovery from the effects of heterologous anti-lymphocyte serum. II. Recovery of the cells involved in antibody production.
    Jeejeebhoy HF; Singla O
    Immunology; 1972 May; 22(5):801-12. PubMed ID: 5063185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive potency and in-vitro activity of antilymphocyte globulin.
    Greaves MF; Tursi A; Playfair JH; Torrigiani G; Zamir R; Roitt IM
    Lancet; 1969 Jan; 1(7585):68-72. PubMed ID: 4180096
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of the xenogeneic and allogeneic components of bivalent rabbit antilymphocyte serum.
    Stewart PB; Cohen V; Bell R
    Nature; 1969 May; 222(5193):592-3. PubMed ID: 4889309
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of minimal doses of lymphoid cells for production of heterologous antilymphocyte serum.
    Gozzo JJ; Wood ML; Monaco AP
    Transplant Proc; 1971 Mar; 3(1):779-83. PubMed ID: 4937972
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of heterologous antilymphocyte serum on lymphoid cells labeled with 5-iodo-2-deoxyuridine-125-I.
    Taub RN
    Fed Proc; 1970; 29(1):142-4. PubMed ID: 4904619
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and in vitro assay of effective and ineffective antilymphocyte sera.
    Davis RC; Cooperband SR; Mannick JA
    Surgery; 1969 Jul; 66(1):58-64. PubMed ID: 4892313
    [No Abstract]   [Full Text] [Related]  

  • 20. Variations in rabbit antimouse lymphocyte sera caused by lymphocytes of differing origins in the immunizing inocula.
    Miller J; Tanner D; Cohn R
    Transplantation; 1970 Apr; 9(4):352-65. PubMed ID: 4927383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.